Skip to main content
Clinical Trials/NL-OMON36467
NL-OMON36467
Completed
Not Applicable

Oral and gastric contributions to satiety II: effects of energy content. - MoMa Study

estec0 sites40 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
overweight and obesity
Sponsor
estec
Enrollment
40
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
estec

Eligibility Criteria

Inclusion Criteria

  • Male, healthy (based on subjects own judgement), aged between 18 and 40 years, BMI between 18\.5 and 25 kg/m2, stable body weight (no changes larger than 5kg over the past 2 months)

Exclusion Criteria

  • Smoking or drug use
  • Taking any medication, except for light pain relieving medications which are available over the counter (aspirin or paracetamol).
  • Gastro\-intestinal diseases
  • Diabetes, thyroid diseases or any other endocrine disorders
  • Problems with the respiratory tract, such as hyperventilation, asthma or bronchitis, which can cause problems when the naso\-gastric tube is inserted.
  • Lack of appetite for any reason
  • Restraint eating DEBQ score \>\= 2\.26 (above average)
  • Hypersensitivity or food allergy for products used in this study
  • Currently participating or having participated in a clinical trial during the last 3 months prior to the beginning of this study.
  • Working at, or doing an MSc. thesis at the Division of Human Nutrition

Outcomes

Primary Outcomes

Not specified

Similar Trials